SI2416794T1 - Rastlinska sestava za zdravljenje ali preprečevanje virusnih bolezni, ki se prenašajo s krvjo, ki jih povzroči virus človeške imunske pomanjkljivosti (HIV) ali hepatitis C - Google Patents
Rastlinska sestava za zdravljenje ali preprečevanje virusnih bolezni, ki se prenašajo s krvjo, ki jih povzroči virus človeške imunske pomanjkljivosti (HIV) ali hepatitis CInfo
- Publication number
- SI2416794T1 SI2416794T1 SI200930874T SI200930874T SI2416794T1 SI 2416794 T1 SI2416794 T1 SI 2416794T1 SI 200930874 T SI200930874 T SI 200930874T SI 200930874 T SI200930874 T SI 200930874T SI 2416794 T1 SI2416794 T1 SI 2416794T1
- Authority
- SI
- Slovenia
- Prior art keywords
- hepatitis
- hiv
- prevention
- treatment
- immunodeficiency virus
- Prior art date
Links
- 208000035049 Blood-Borne Infections Diseases 0.000 title 1
- 241000725303 Human immunodeficiency virus Species 0.000 title 1
- 208000006454 hepatitis Diseases 0.000 title 1
- 231100000283 hepatitis Toxicity 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 230000003612 virological effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09784375.9A EP2416794B1 (fr) | 2009-04-10 | 2009-04-10 | Composition à base de plantes pour le traitement ou la prévention de maladies virales du sang causées par le virus de l' immunodéficience humaine (vih) ou l'hépatite c |
PCT/FR2009/050678 WO2010116048A1 (fr) | 2009-04-10 | 2009-04-10 | Composition à base de plantes pour le traitement ou la prévention de maladies virales du sang telles que les maladies causées par le virus de l' immunodéficience humaine (vih) ou l'hépatite c |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2416794T1 true SI2416794T1 (sl) | 2014-05-30 |
Family
ID=41723043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200930874T SI2416794T1 (sl) | 2009-04-10 | 2009-04-10 | Rastlinska sestava za zdravljenje ali preprečevanje virusnih bolezni, ki se prenašajo s krvjo, ki jih povzroči virus človeške imunske pomanjkljivosti (HIV) ali hepatitis C |
Country Status (16)
Country | Link |
---|---|
US (1) | US20120076849A1 (sl) |
EP (1) | EP2416794B1 (sl) |
JP (1) | JP5472445B2 (sl) |
CN (1) | CN102458432B (sl) |
AU (1) | AU2009344046B2 (sl) |
CA (1) | CA2758365A1 (sl) |
CY (1) | CY1115326T1 (sl) |
DK (1) | DK2416794T3 (sl) |
ES (1) | ES2452482T3 (sl) |
HR (1) | HRP20140230T8 (sl) |
PL (1) | PL2416794T3 (sl) |
PT (1) | PT2416794E (sl) |
RS (1) | RS53216B (sl) |
RU (1) | RU2543319C2 (sl) |
SI (1) | SI2416794T1 (sl) |
WO (1) | WO2010116048A1 (sl) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2973249B1 (fr) * | 2011-03-28 | 2014-02-07 | Centre Nat Rech Scient | Utilisation de l'epigallocatechine gallate comme agent antiviral contre les infections par le virus de l'hepatite c |
KR101899122B1 (ko) * | 2017-04-20 | 2018-09-21 | 주식회사 제넨셀 | C형 간염 바이러스 감염 질환의 예방 또는 치료용 약학 조성물 |
WO2021226037A1 (en) * | 2020-05-04 | 2021-11-11 | Sulfagenix, Inc. | Treatment of viral infections |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US202932A (en) * | 1878-04-30 | Improvement in hog-cholera compounds | ||
FR2296426A1 (fr) * | 1975-01-03 | 1976-07-30 | Durupt Marie Helene | Elixir |
US4692342A (en) * | 1985-11-14 | 1987-09-08 | Nabisco Brands, Inc. | Process for honey-roasting nuts |
JPH0683635B2 (ja) * | 1986-03-28 | 1994-10-26 | 株式会社ロツテ | 抗菌作用の増強されたかりんエキスを配合した菓子類 |
FR2619716B1 (fr) * | 1987-08-26 | 1991-02-08 | Letourneur Bernard | Medicament et produit veterinaire pour le traitement de la sterilite |
FR2622800B1 (fr) * | 1987-11-05 | 1990-03-23 | Hauser Denis | Procede de preparation d'un produit de lutte contre des affections virales en particulier des affections virales cutaneo-muqueuses,compositions pharmaceutiques et medicaments obtenus a partir de ce procede |
JPH02270824A (ja) * | 1989-04-13 | 1990-11-05 | Snow Brand Milk Prod Co Ltd | 逆転写酵素阻害剤 |
US5411733A (en) * | 1992-04-27 | 1995-05-02 | Hozumi; Toyoharu | Antiviral agent containing crude drug |
DE4490853D2 (de) * | 1993-02-26 | 1996-06-27 | Ina Levi | Behandlung von (Retro)viralen Erkrankungen sowie Verfahren zur Herstellung einer pharmazeutischen Zubereitung |
CN1300623A (zh) * | 1999-12-20 | 2001-06-27 | 张发平 | 一种中成药 |
US6641801B1 (en) * | 2000-04-03 | 2003-11-04 | Love Lives | Gargle method to reduce the duration of common cold symptoms |
US6841174B2 (en) * | 2000-09-20 | 2005-01-11 | Zeyad Technologies Llc | Herbal compositions and treatment methods |
US20040147605A1 (en) * | 2001-05-25 | 2004-07-29 | Yoichi Onuki | Drug preparations |
GEP20032886B (en) * | 2001-08-22 | 2003-02-25 | Maka Burdiladze | Plant Species for Treatment of Chronic Hepatite |
KR20010099494A (ko) * | 2001-10-09 | 2001-11-09 | 이영성, 권두한 | 큰등골짚신나물로부터 분리한 b형 간염바이러스 표면항원억제물질과 그 추출방법 및 용도 |
AU2003237060A1 (en) * | 2002-06-29 | 2004-01-19 | Biokorea Co., Ltd | (e)-1-(((2e, 4e)-1-hexyl-2,4-octadecadienyl)oxy)-2-hydroxydiazine and a pharmaceutical composition for treating hepatitis |
JP2004161623A (ja) * | 2002-11-11 | 2004-06-10 | Noevir Co Ltd | 水性スティック状抗アクネ用組成物 |
DE202005007603U1 (de) * | 2005-05-13 | 2005-08-04 | HD Health Development GmbH | Zusammensetzung umfassend eine Kombination aus Arganöl und Schwarzkümmelöl |
FR2901699A1 (fr) * | 2006-06-06 | 2007-12-07 | Christian Maret | Compositions dont les proprietes sont dues a l'association d'elements synergises, leur procede de preparation et leurs utilisations en cosmetique ou hygiene |
-
2009
- 2009-04-10 PL PL09784375T patent/PL2416794T3/pl unknown
- 2009-04-10 JP JP2012504043A patent/JP5472445B2/ja not_active Expired - Fee Related
- 2009-04-10 CA CA2758365A patent/CA2758365A1/fr not_active Abandoned
- 2009-04-10 RU RU2011143088/15A patent/RU2543319C2/ru not_active IP Right Cessation
- 2009-04-10 WO PCT/FR2009/050678 patent/WO2010116048A1/fr active Application Filing
- 2009-04-10 AU AU2009344046A patent/AU2009344046B2/en not_active Ceased
- 2009-04-10 ES ES09784375.9T patent/ES2452482T3/es active Active
- 2009-04-10 DK DK09784375.9T patent/DK2416794T3/en active
- 2009-04-10 SI SI200930874T patent/SI2416794T1/sl unknown
- 2009-04-10 CN CN200980159739.4A patent/CN102458432B/zh not_active Expired - Fee Related
- 2009-04-10 EP EP09784375.9A patent/EP2416794B1/fr active Active
- 2009-04-10 PT PT97843759T patent/PT2416794E/pt unknown
- 2009-04-10 RS RS20140126A patent/RS53216B/en unknown
- 2009-04-10 US US13/263,810 patent/US20120076849A1/en not_active Abandoned
-
2014
- 2014-03-12 HR HRP20140230TT patent/HRP20140230T8/hr unknown
- 2014-03-18 CY CY20141100216T patent/CY1115326T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
HRP20140230T1 (hr) | 2014-05-09 |
RU2011143088A (ru) | 2013-05-10 |
DK2416794T3 (en) | 2014-03-17 |
US20120076849A1 (en) | 2012-03-29 |
JP5472445B2 (ja) | 2014-04-16 |
AU2009344046B2 (en) | 2014-10-30 |
CN102458432A (zh) | 2012-05-16 |
EP2416794A1 (fr) | 2012-02-15 |
CA2758365A1 (fr) | 2010-10-14 |
CY1115326T1 (el) | 2017-01-04 |
PT2416794E (pt) | 2014-03-17 |
RS53216B (en) | 2014-08-29 |
WO2010116048A1 (fr) | 2010-10-14 |
EP2416794B1 (fr) | 2013-12-25 |
HRP20140230T8 (hr) | 2015-12-04 |
CN102458432B (zh) | 2015-04-22 |
WO2010116048A8 (fr) | 2011-11-10 |
PL2416794T3 (pl) | 2014-09-30 |
RU2543319C2 (ru) | 2015-02-27 |
ES2452482T3 (es) | 2014-04-01 |
AU2009344046A1 (en) | 2011-11-10 |
JP2012523396A (ja) | 2012-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010118367A3 (en) | Antiviral pyrimidines | |
WO2011007230A3 (en) | Lupeol-type triterpene derivatives as antivirals | |
IL217243A (en) | Theophane 2-carboxylic acid derivatives, including pharmaceutical preparations and their uses for the preparation of flaviviridiae virus infections and hepatitis c virus infections | |
MX346264B (es) | Compuestos antivirales. | |
EP2853531A3 (en) | Antiviral compounds | |
MY170941A (en) | Pyrimidine derivatives for the treatment of viral infections | |
HK1197026A1 (en) | Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection | |
MX2013003634A (es) | Derivados policiclicos heterociclicos y metodos de uso de los mismos para el tratamiento de enfermedades virales. | |
PT3542817T (pt) | Anticorpos de neutralização do vírus de imunodeficiência humana (hiv) | |
WO2009094191A3 (en) | Methods of treating viral infections | |
SG179082A1 (en) | Method for the preparation of an influenza virus | |
MX2013000242A (es) | Tratamiento de enfermedades relacionadas con el virus de hepatitis c que usa hidroxicloroquina o una combinacion de hidroxicloroquina y un agente antiviral. | |
JO3281B1 (ar) | مركبات بينزوفوران لمعالجة عدوى فيروس إلتهاب الكبد الوبائي | |
EP2555798A4 (en) | METHOD AND COMPOSITIONS FOR INHIBITING HIV TRANSMISSIONS | |
HK1201262A1 (en) | Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection (hcv) | |
HRP20140230T8 (hr) | Biljna kompozicija za lijeäśenje ili prevenciju virusnih bolesti koje se prenose putem krvi, kao što su bolesti izazvane virusom humane imunodeficijencije (hiv) ili hepatitis c virusom | |
MX2011006516A (es) | Terapia de combinacion de virus de hepatitis c. | |
MY171497A (en) | Crystalline forms of dihydropyrimidine derivatives | |
GB2463584A (en) | Carbohydrate-lipid constructs and their use in preventing or treating viral infection | |
GB201008123D0 (en) | Novel compounds | |
PL391694A1 (pl) | Modyfikowane 2',3'-dideoksynukleozydy do leczenia zakażeń szczepami ludzkiego wirusa nabytego niedoboru odporności (HIV) wykazującymi oporność wielolekową, sposób ich wytwarzania oraz środek farmaceutyczny zawierający te nukleozydy |